Software & Services
Etherstack (ASX:ESK) is pleased to present commentary on the Company's activities in H1 FY20, to accompany the lodgement of its Appendix 4C cash report for the quarter ending 30 June 2020.
The Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that the Company's wholly owned subsidiary, BetMakers DNA Pty Ltd, has signed an agreement with PointsBet New Jersey Inc. to begin Fixed Odds betting on horseracing in the New Jersey market
The Board of BetMakers Technology Group Ltd (ASX:BET) (FRA:T07) is pleased to announce the start of thoroughbred racing at Monmouth Park, New Jersey, U.S., and the subsequent international distribution of the product via BetMakers' Global Racing Network ("GRN").
Etherstack (ASX:ESK) hereby provides additional information in connection with the ASX announcement dated 30 June 2020 titled "Etherstack signs Global Teaming Agreement with Samsung for 4G/5G Public Safety"
Etherstack plc (ASX:ESK) has entered a global teaming agreement with Samsung Electronics to deliver next generation Mission Critical Push To Talk (MCPTT) over LTE solutions to telecommunications carriers and governments across the globe, utilising Etherstack's digital LMR (Land Mobile Radio) softswitching technologies embedded within Samsung's advanced network solutions.
iSignthis Ltd (ASX:ISX) (FRA:TA8) discloses that the Company has made an application to the Federal Court to extend a Statement of Claim against the ASX to address the ASX's Statement of Reasons, and its veracity under s1041H of the Corporations Act.
Further to the ASX announcement dated 16 June 2020, the Board of BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that the Company has completed the issue and allotment of 94,594,595 fully paid ordinary shares to raise A$35 million.
BetMakers Technology Group Limited (ASX:BET) (FRA:T07) is pleased to announce that it has received firm commitments to raise A$35 million by way of a placement to sophisticated and institutional investors at an offer price of A$0.37 per new fully paid ordinary share.
Etherstack Plc (ASX:ESK) has invested in excess of $20 million into our suite of intellectual property assets over an extended period and has developed a substantial intellectual property portfolio that generates a diverse range of revenue streams from multiple technology areas.
iSIgnthis Ltd (ASX:ISX) (FRA:TA8) is pleased to advise that it has met its certification requirements with the Central Bank of Lithuania for SEPA Instant thresholds to be lifted from EUR15,000 per transaction to EUR100,000 per transaction limit, as from 1st July 2020.
Banking & Finance
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
- NSX Limited (ASX:NSX) Company Update
- ASIC vs iSignthis Ltd and Nickolas John Karantzis
Oil Gas & Energy
- TMK Energy Limited (ASX:TMK) Drilling Contract Signed with Canadian Listed Drilling Company
- Deep Yellow Limited (ASX:DYL) Highly Encouraging Mini-Pilot Testwork From Mulga Rock
- Beetaloo Energy Australia Limited (ASX:BTL) Completion of Carpentaria-5H Hydraulic Stimulation
- State Gas Limited (ASX:GAS) Advances Rolleston West
- Central Petroleum Limited (ASX:CTP) Operations and Activities Update
- Beetaloo Energy Australia Limited (ASX:BTL) Traditional Owners Consent to the Sale of Appraisal Gas
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) AMA Grants Reimbursement Code for Next-Gen PromarkerD Test
- Proteomics International Laboratories Ltd (ASX:PIQ) Funding Boost for Precision Diagnostics Proteomics Facility
- Proteomics International Laboratories Ltd (ASX:PIQ) First Patent for Endometriosis Blood Test - Granted in Japan
- Proteomics International Laboratories Ltd (ASX:PIQ) Next-gen PromarkerD test system released for predicting Diabetic Kidney Disease
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Launched into the US at Major Diabetes Conference
- Proteomics International Laboratories Ltd (ASX:PIQ) A Landmark in Non-Invasive Esophageal Cancer Diagnosis